NCT00204789View on ClinicalTrials.gov

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Post-solid Organ TransplantSkin Neoplasms
Interventions
DRUG

Difluoromethylornithine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00204789 - Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients | Biotech Hunter | Biotech Hunter